Skip to main content
Clinical Trials/NCT04779515
NCT04779515
Completed
Not Applicable

Effect of Low-pressure Pneumoperitoneum on Pain and Inflammation Post Laparoscopic Cholecystectomy: A Randomized, Double-blinded, Controlled, Clinical Trial.

University of Jordan1 site in 1 country100 target enrollmentJanuary 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pneumoperitoneum
Sponsor
University of Jordan
Enrollment
100
Locations
1
Primary Endpoint
change from baseline in ESR value at 24hr post op
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to assess the effect of low-pressure pneumoperitoneum on post operative pain and inflammation in patients undergoing elective laparoscopic cholecystectomy by comparing it to standard practice.

Detailed Description

After obtaining informed consent from eligible study participants. patients were randomized into one of two masked groups, labelled red and green. The red-label group was operated at standard-pressure pneumoperitoneum, while the green-label group was operated at low-pressure pneumoperitoneum. Baseline blood samples were obtained pre-operatively for ten inflammatory markers, patients' demographics and intra-operative details collected, then post-operative pain and change in inflammatory markers were followed.

Registry
clinicaltrials.gov
Start Date
January 20, 2020
End Date
January 22, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hanan Ibrahim Mansour

Dr. Hanan Mansour, post-graduate, general surgery resident

University of Jordan

Eligibility Criteria

Inclusion Criteria

  • Elective admission for laparoscopic cholecystectomy

Exclusion Criteria

  • Current or previous diagnosis of acute cholecystitis confirmed by ultrasound
  • previous GI surgeries, except bariatric and anti-reflux surgeries
  • Currently on immunosuppressant agents
  • Pregnancy
  • Breastfeeding
  • Currently diagnosed with drug addiction
  • American Society of Anesthesiologists (ASA) score 3 and more

Outcomes

Primary Outcomes

change from baseline in ESR value at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in erythrocyte sedimentation rate value as inflammatory marker post-op in millimeters per hour. change = (post-op ESR) - (baseline ESR)

change from baseline in TNF level at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in tumor necrosis factor alpha level as inflammatory marker post-op in pg/mL change = (post-op TNF) - (baseline TNF)

change from baseline in WBC count at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in white blood cycles count as inflammatory marker post-op in 1000 cells per cubic millimeter of blood. change = (post-op WBC count) - (baseline WBC count)

change from baseline in pain on the 11-point short pain scale (SPS-11) at hour 12 post-op

Time Frame: baseline and 12 hours post-op

the SPS-11 is a validated, self-reported numeric instrument assessing pain intensity, ranging from 0 to 10; where 0 is no pain, and 10 is the worst pain felt ever. change = (pain score at 12-hr post-op) - (baseline pain score assessed at 6-hr post-op)

change from baseline in pain on the 11-point short pain scale (SPS-11) at hour 24 post-op

Time Frame: baseline and 24 hours post-op

the SPS-11 is a validated, self-reported numeric instrument assessing pain intensity, ranging from 0 to 10; where 0 is no pain, and 10 is the worst pain felt ever. change = (pain score at 24-hr post-op) - (baseline pain score assessed at 6-hr post-op)

change from baseline in cortisol level at 4hr post op

Time Frame: baseline and 4 hours post-op

calculate the rise in cortisol level as inflammatory marker post-op in nmol/L change = (post-op cortisol ) - (baseline cortisol )

change from baseline in pain on the 11-point short pain scale (SPS-11) at day 7 post-op

Time Frame: baseline and 7 days post-op

the SPS-11 is a validated, self-reported numeric instrument assessing pain intensity, ranging from 0 to 10; where 0 is no pain, and 10 is the worst pain felt ever. change = (pain score at post-op day 7) - (baseline pain score assessed at 6-hr post-op)

change from baseline in Plt count at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in platelets count as inflammatory marker post-op in × 10\^9/L of blood change = (post-op Plt count) - (baseline Plt count)

change from baseline in CRP level at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in C reactive protein level as inflammatory marker post-op in mg/L change = (post-op CRP) - (baseline CRP)

change from baseline in IL-6 level at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in interleukin 6 level as inflammatory marker post-op in pg/mL change = (post-op IL-6) - (baseline IL-6)

change from baseline in IL-1 level at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in interleukin 1 level as inflammatory marker post-op in pg/mL change = (post-op IL-1) - (baseline IL-1)

change from baseline in Alb level at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the drop in albumin level as inflammatory marker post-op in g/dL change = (baseline Alb) - (post-op baseline Alb)

change from baseline in IL-17 level at 24hr post op

Time Frame: baseline and 24 hours post-op

calculate the rise in interleukin 17 level as inflammatory marker post-op in pg/mL change = (post-op IL-17) - (baseline IL-17)

Secondary Outcomes

  • Difference in surgery time among two groups(through study completion, an average of 1 year)
  • Difference in surgery difficulty level among two groups(through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials